Literature DB >> 1651414

Murine infection by vesicular stomatitis virus: initial characterization of the H-2d system.

J M Forger1, R T Bronson, A S Huang, C S Reiss.   

Abstract

BALB/c mice and congenic H-2Ld-deficient BALB/c-H-2dm2 (dm2) mice were experimentally infected intranasally with isolates of vesicular stomatitis virus (VSV). The survival of infected hosts, viral replication in lungs and brains, and histopathologic in the two mouse strains were compared. In both strains of mice, mortality occurred during the period 7 to 10 days postinfection. However, dm2 mice were relatively resistant to lethal infections. Viral replication occurred at low levels in the lungs of both strains and did not evoke significant pathologic changes. In contrast, viral replication in the brains was much greater; in the BALB/c strain, this was accompanied by more frequent and more severe pathologic changes. In general, mice surviving at day 10 had effectively cleared virus from central nervous system but not respiratory sites. Evidence is presented that viral replication occurs first in the nasal cavity and is transmitted both to the lungs and to the olfactory bulb where focal cytopathology occurs. Virus enters the ventricles, causing encephalitis; necrosis occurs around the ventricles and in the lumbosacral region of the spinal cord. Necrotic lesions were accompanied by mononuclear infiltration. Mice immunized with virus of the same serotype or with a vaccinia virus hybrid encoding the VSV glycoprotein were protected from lethal infection; in contrast, mice immunized with heterotypic virus were susceptible to challenge.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1651414      PMCID: PMC248957     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

Review 1.  Recombinant vaccinia viruses as vectors for studying T lymphocyte specificity and function.

Authors:  J R Bennink; J W Yewdell
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

2.  Sequences of the major antibody binding epitopes of the Indiana serotype of vesicular stomatitis virus.

Authors:  S B Vandepol; L Lefrancois; J J Holland
Journal:  Virology       Date:  1986-01-30       Impact factor: 3.616

3.  Asymmetric budding of viruses in epithelial monlayers: a model system for study of epithelial polarity.

Authors:  E Rodriguez Boulan; D D Sabatini
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

4.  Selective infections of olfactory and respiratory epithelium by vesicular stomatitis and Sendai viruses.

Authors:  B Lundh; K Kristensson; E Norrby
Journal:  Neuropathol Appl Neurobiol       Date:  1987 Mar-Apr       Impact factor: 8.090

5.  Biological basis of rabies virus neurovirulence in mice: comparative pathogenesis study using the immunoperoxidase technique.

Authors:  A C Jackson
Journal:  J Virol       Date:  1991-01       Impact factor: 5.103

6.  T cell hybridomas define the class II MHC-restricted response to vesicular stomatitis virus infection.

Authors:  M A Petrarca; C S Reiss; D C Diamond; J Boni; S J Burakoff; D V Faller
Journal:  Microb Pathog       Date:  1988-11       Impact factor: 3.738

7.  VSV G protein induces murine cytolytic T lymphocytes.

Authors:  C S Reiss; S S Chen; A S Huang; R Doherty
Journal:  Microb Pathog       Date:  1986-06       Impact factor: 3.738

8.  Defective interfering virus particles modulate virulence.

Authors:  D R Cave; F M Hendrickson; A S Huang
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

9.  INDUCTION OF PARTIAL SPECIFIC HETEROTYPIC IMMUNITY IN MICE BY A SINGLE INFECTION WITH INFLUENZA A VIRUS.

Authors:  J L SCHULMAN; E D KILBOURNE
Journal:  J Bacteriol       Date:  1965-01       Impact factor: 3.490

10.  Recognition of cloned vesicular stomatitis virus internal and external gene products by cytotoxic T lymphocytes.

Authors:  J W Yewdell; J R Bennink; M Mackett; L Lefrancois; D S Lyles; B Moss
Journal:  J Exp Med       Date:  1986-06-01       Impact factor: 14.307

View more
  28 in total

Review 1.  Nonsegmented negative-strand viruses as vaccine vectors.

Authors:  Alexander Bukreyev; Mario H Skiadopoulos; Brian R Murphy; Peter L Collins
Journal:  J Virol       Date:  2006-11       Impact factor: 5.103

2.  Peripheral dendritic cells are essential for both the innate and adaptive antiviral immune responses in the central nervous system.

Authors:  Christina D Steel; Suzanne M Hahto; Richard P Ciavarra
Journal:  Virology       Date:  2009-03-04       Impact factor: 3.616

3.  Distinct macrophage subpopulations regulate viral encephalitis but not viral clearance in the CNS.

Authors:  Christina D Steel; Woong-Ki Kim; Larry D Sanford; Laurie L Wellman; Sandra Burnett; Nico Van Rooijen; Richard P Ciavarra
Journal:  J Neuroimmunol       Date:  2010-09-14       Impact factor: 3.478

4.  Vaccination with a recombinant vesicular stomatitis virus expressing an influenza virus hemagglutinin provides complete protection from influenza virus challenge.

Authors:  A Roberts; E Kretzschmar; A S Perkins; J Forman; R Price; L Buonocore; Y Kawaoka; J K Rose
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

5.  Sleep and behavior during vesicular stomatitis virus induced encephalitis in BALB/cJ and C57BL/6J mice.

Authors:  Mayumi Machida; Marta A Ambrozewicz; Kimberly Breving; Laurie L Wellman; Linghui Yang; Richard P Ciavarra; Larry D Sanford
Journal:  Brain Behav Immun       Date:  2013-09-18       Impact factor: 7.217

6.  Vesicular stomatitis virus infection of the central nervous system activates both innate and acquired immunity.

Authors:  Z Bi; M Barna; T Komatsu; C S Reiss
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

7.  Central neuropathogenesis of vesicular stomatitis virus infection of immunodeficient mice.

Authors:  B S Huneycutt; Z Bi; C J Aoki; C S Reiss
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

8.  In vivo biodistribution of a highly attenuated recombinant vesicular stomatitis virus expressing HIV-1 Gag following intramuscular, intranasal, or intravenous inoculation.

Authors:  J Erik Johnson; John W Coleman; Narender K Kalyan; Priscilla Calderon; Kevin J Wright; Jennifer Obregon; Eleanor Ogin-Wilson; Robert J Natuk; David K Clarke; Stephen A Udem; David Cooper; R Michael Hendry
Journal:  Vaccine       Date:  2009-03-13       Impact factor: 3.641

9.  Role of peripheral immune response in microglia activation and regulation of brain chemokine and proinflammatory cytokine responses induced during VSV encephalitis.

Authors:  Christina D Steel; Kimberly Breving; Susan Tavakoli; Woong-Ki Kim; Larry D Sanford; Richard P Ciavarra
Journal:  J Neuroimmunol       Date:  2013-12-11       Impact factor: 3.478

10.  Effects of ovarian steroids on immunoglobulin-secreting cell function in healthy women.

Authors:  Fabien X Lü; Zhongmin Ma; Susie Moser; Thomas G Evans; Christopher J Miller
Journal:  Clin Diagn Lab Immunol       Date:  2003-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.